Global serum profiling: an opportunity for earlier cancer detection

[1]  James M. Cameron,et al.  Liquid biopsies: the future of cancer early detection , 2023, Journal of Translational Medicine.

[2]  A. Fendrick,et al.  The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA , 2022, PharmacoEconomics.

[3]  Peter Freese,et al.  Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multi-Cancer Early Detection Tests to Assess the Clinical Significance of Cancers. , 2022, The American journal of pathology.

[4]  Yiping Yang,et al.  Recent Advances and Challenges in Cancer Immunotherapy , 2022, Cancers.

[5]  James M. Cameron,et al.  Liquid Biopsy for Pancreatic Cancer Detection Using Infrared Spectroscopy , 2022, Cancers.

[6]  James M. Cameron,et al.  Multicancer early detection with a spectroscopic liquid biopsy platform. , 2022, Journal of Clinical Oncology.

[7]  S. Hindocha,et al.  The Role of Artificial Intelligence in Early Cancer Diagnosis , 2022, Cancers.

[8]  James M. Cameron,et al.  Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer , 2022, Neuro-oncology advances.

[9]  C. Tomasetti,et al.  Evaluating the impact of multicancer early detection testing on health and economic outcomes: Toward a decision modeling strategy , 2022, Cancer.

[10]  N. Pavlova,et al.  The hallmarks of cancer metabolism: Still emerging. , 2022, Cell metabolism.

[11]  Abhijit A. Patel,et al.  Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics , 2022, Nature Biomedical Engineering.

[12]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[13]  E. Diamandis,et al.  Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm , 2021, Diagnostics.

[14]  M. Paraskevaidi,et al.  Clinical applications of infrared and Raman spectroscopy in the fields of cancer and infectious diseases , 2021, Applied Spectroscopy Reviews.

[15]  T. Karpiński,et al.  Nanoparticles for Cancer Therapy: Current Progress and Challenges , 2021, Nanoscale Research Letters.

[16]  P. Mohanan,et al.  Cascade of immune mechanism and consequences of inflammatory disorders , 2021, Phytomedicine.

[17]  C. Swanton,et al.  Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  E. Fung,et al.  Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA , 2021, Clinical Cancer Research.

[19]  M. Duffy,et al.  Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon? , 2021, Clinical chemistry and laboratory medicine.

[20]  S. Skates,et al.  Multicancer Screening: One Size Does Not Fit All. , 2021, JCO precision oncology.

[21]  James M. Cameron,et al.  Interrogation of IDH1 Status in Gliomas by Fourier Transform Infrared Spectroscopy , 2020, Cancers.

[22]  N. Darwiche.  Epigenetic mechanisms and the hallmarks of cancer: an intimate affair. , 2020, American journal of cancer research.

[23]  J. Campisi,et al.  Role of immune cells in the removal of deleterious senescent cells , 2020, Immunity & Ageing.

[24]  E. Diamandis,et al.  Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[25]  D. Berry,et al.  Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  David J. Anderson,et al.  Biofluid Diagnostics by FTIR Spectroscopy: A Platform Technology for Cancer Detection. , 2020, Cancer letters.

[27]  S. Ergün,et al.  Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy , 2020, Frontiers in Molecular Biosciences.

[28]  Jiyeon Kim,et al.  Amino acids in cancer , 2020, Experimental & Molecular Medicine.

[29]  G. Ciofani,et al.  Innovative approaches for cancer treatment: current perspectives and new challenges , 2019, Ecancermedicalscience.

[30]  F. Greten,et al.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.

[31]  S. Stewart,et al.  Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.

[32]  L. Bel’skaya.  Use of IR Spectroscopy in Cancer Diagnosis. A Review , 2019, Journal of Applied Spectroscopy.

[33]  B. Stanger,et al.  Cellular Plasticity in Cancer. , 2019, Cancer discovery.

[34]  E. Diamandis,et al.  Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection , 2018, BMC Medicine.

[35]  Zena Werb,et al.  Roles of the immune system in cancer: from tumor initiation to metastatic progression , 2018, Genes & development.

[36]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[37]  J. Jett,et al.  P2.13-013 Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort , 2017 .

[38]  James D. Brenton,et al.  Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.

[39]  Laurent Schwartz,et al.  The Warburg Effect and the Hallmarks of Cancer. , 2017, Anti-cancer agents in medicinal chemistry.

[40]  H. Aboul‐Enein,et al.  Vibrational Spectroscopy in Body Fluids Analysis , 2017, Critical reviews in analytical chemistry.

[41]  John T. Wei,et al.  A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. , 2016, JAMA oncology.

[42]  A. Brodbelt,et al.  Combining random forest and 2D correlation analysis to identify serum spectral signatures for neuro-oncology. , 2016, The Analyst.

[43]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[44]  H. Aboul‐Enein,et al.  Applications of FT-IR Spectrophotometry in Cancer Diagnostics , 2015, Critical reviews in analytical chemistry.

[45]  Deepak Mittal,et al.  New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. , 2014, Current opinion in immunology.

[46]  Cynthia L Sears,et al.  Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.

[47]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[48]  R. Schreiber,et al.  Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy , 2013, Annals of the New York Academy of Sciences.

[49]  R. Chammas.  Tumors as complex organs: are cancers manageable through the modification of their microenvironment? , 2013, BMC Proceedings.

[50]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[51]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[52]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[53]  G. Poste.  Bring on the biomarkers , 2011, Nature.

[54]  Graeme I Murray,et al.  Current and emerging concepts in tumour metastasis , 2010, The Journal of pathology.

[55]  J. Thomas,et al.  Transmission of donor melanoma by organ transplantation. , 2010, The Lancet. Oncology.

[56]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[57]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[58]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[59]  L. Coussens,et al.  Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity , 2010, Cancer and Metastasis Reviews.

[60]  Yosef Yarden,et al.  Roles for growth factors in cancer progression. , 2010, Physiology.

[61]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[62]  C. Vajdic,et al.  Cancer incidence and risk factors after solid organ transplantation , 2009, International journal of cancer.

[63]  O. Feron,et al.  Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  N. Hynes,et al.  ErbB receptors and signaling pathways in cancer. , 2009, Current opinion in cell biology.

[65]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[66]  Jean-Philippe Coppé.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2009 .

[67]  L. Galluzzi,et al.  Necroptosis: A Specialized Pathway of Programmed Necrosis , 2008, Cell.

[68]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[69]  R. Schreiber,et al.  Immune‐mediated dormancy: an equilibrium with cancer , 2008, Journal of leukocyte biology.

[70]  J. Sage,et al.  Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.

[71]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[72]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[73]  Rosario Perona,et al.  Cell signalling: growth factors and tyrosine kinase receptors , 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[74]  M. Blasco.  Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[75]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[76]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[77]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[78]  K. Plate,et al.  Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.

[79]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[80]  James M. Cameron,et al.  Development of high-throughput ATR-FTIR technology for rapid triage of brain cancer. , 2019, Nature communications.

[81]  Walter F. Bodmer.  Human Genome Project , 2013 .

[82]  T. Tollefsbol,et al.  DNA methylation detection: bisulfite genomic sequencing analysis. , 2011, Methods in molecular biology.

[83]  M. Paty.  The Exact Sciences , 2006 .

[84]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .